Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11744881 Treatment of amyotrophic lateral sclerosis using botulinum toxin

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 29, 2021
Date of Patent
September 5, 2023
Patent Application Number
17215082
Patent Citations
‌
US Patent 10973873 Treatment of asthma using botulinum toxin
‌
US Patent 10987441 Disinfecting UVC lamp appliance
‌
US Patent 7655244 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
‌
US Patent 8470337 Therapeutic treatments using botulinum neurotoxin
‌
US Patent 8734810 Botulinum toxin treatments of neurological and neuropsychiatric disorders
‌
US Patent 8852163 Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods
‌
US Patent 8972004 Magnetic stimulation devices and methods of therapy
‌
US Patent 9254314 Treatment of social anxiety disorder, obsessive compulsive disorder and panic disorder using botulinum toxin
‌
US Patent 9707207 Method for diagnosing, preventing, and treating neurological diseases
‌
US Patent 10011823 Engineered botulinum neurotoxin
•••
Patent Inventor Names
Roland M. Williams
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11744881
Patent Primary Examiner
‌
Christina M Borgeest

Find more entities like US Patent 11744881 Treatment of amyotrophic lateral sclerosis using botulinum toxin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.